Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

Direct activation of STING in the tumour microenvironment leads to potent and...

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )

Inflammatory microenvironment regulates colorectal cancer progression

Dr Sergei Grivennikov - Fox Chase Cancer Center, Philadelphia, USA

Inflammatory microenvironment regulates colorectal cancer progression ( Dr Sergei Grivennikov - Fox Chase Cancer Center, Philadelphia, USA )

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

Dr Shivaani Kummar - Stanford University, Stanford, USA

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors ( Dr Shivaani Kummar - Stanford University, Stanford, USA )

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia

Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA

The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )

Targeted therapy shows continued promise in patients whose tumours had NTRK...

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France

Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )

MINDACT breast cancer clinical trial: First results and impact on future trial...

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

More from ecancer